Brief: Natco Pharma Announces Completion Of Inspection By USFDA For Pharma Division Located In Kothur Hyderabad, India
19/10/2023 11:41
Oct 19 (Reuters) - Natco Pharma Ltd NATP.NS :
* NATCO PHARMA LTD - COMPLETION OF AN INSPECTION BY USFDA
FOR ITS
PHARMA DIVISION LOCATED IN KOTHUR HYDERABAD, INDIA
* NATCO PHARMA LTD - FACILITY RECEIVED EIGHT (8)
OBSERVATIONS
Source text for Eikon: ID:nNSE4jjFPg
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees